Cargando…
Polymorphism of Promoter Region of TNFRSF1A Gene (−610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients
Every year, about 650 thousand new cases of Head and Neck Cancer (HNC) are diagnosed globally. Apart from surgery, radiotherapy (RTH), chemotherapy (CHT) or its combination is used in the treatment of HNC. One of the most frequent complications and, at the same time, limitations of RTH is oral mucos...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736772/ https://www.ncbi.nlm.nih.gov/pubmed/28401452 http://dx.doi.org/10.1007/s12253-017-0227-1 |
_version_ | 1783287427618570240 |
---|---|
author | Brzozowska, Anna Powrózek, Tomasz Homa-Mlak, Iwona Mlak, Radosław Ciesielka, Marzanna Gołębiowski, Paweł Małecka-Massalska, Teresa |
author_facet | Brzozowska, Anna Powrózek, Tomasz Homa-Mlak, Iwona Mlak, Radosław Ciesielka, Marzanna Gołębiowski, Paweł Małecka-Massalska, Teresa |
author_sort | Brzozowska, Anna |
collection | PubMed |
description | Every year, about 650 thousand new cases of Head and Neck Cancer (HNC) are diagnosed globally. Apart from surgery, radiotherapy (RTH), chemotherapy (CHT) or its combination is used in the treatment of HNC. One of the most frequent complications and, at the same time, limitations of RTH is oral mucositis (OM). Proinflammatory cytokines (including TNF-α) play a key role in the development of OM. Genetic alterations, i.e. single nucleotide polymorphisms (SNPs) within genes encoding for receptors for TNF (ie. TNFRSF1A) may change their function. The aim of this study was to investigate relationship between a polymorphism of TNFRSF1A and occurrence and severity of acute reaction after RTH for HNC patients. Data from 58 HNC patients (stages I-IV) were analyzed. All of them were irradiated using IMRT technique with doses 50-70Gy. Oral mucositis (OM) was evaluated according to RTOG/EORTC guidelines. DNA from HNC patients were isolated from whole blood and genotypes were determined by sequencing method. Patients with TT or GT genotype demonstrated higher risk of manifestation of grade 3 OM in 5th week of RTH (p=0.041; OR=9.240; 95% CI: 1.101–77.581) compared to GG carriers. Similarly, high risk of grade 3 OM in patients with T allele presence was noted in 6th week (p=0.030; OR=10.50; 95%CI:1.257–87.690) and in 7th week (p=0.008; OR=5.625; 95% CI: 1.584–19.975) of treatment compared to patients with GG homozygote. Our results indicate an association between SNP of TNFRSF1A (rs4149570) gene and risk of more severe OM related to radiation therapy for HNC patients. |
format | Online Article Text |
id | pubmed-5736772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-57367722017-12-26 Polymorphism of Promoter Region of TNFRSF1A Gene (−610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients Brzozowska, Anna Powrózek, Tomasz Homa-Mlak, Iwona Mlak, Radosław Ciesielka, Marzanna Gołębiowski, Paweł Małecka-Massalska, Teresa Pathol Oncol Res Original Article Every year, about 650 thousand new cases of Head and Neck Cancer (HNC) are diagnosed globally. Apart from surgery, radiotherapy (RTH), chemotherapy (CHT) or its combination is used in the treatment of HNC. One of the most frequent complications and, at the same time, limitations of RTH is oral mucositis (OM). Proinflammatory cytokines (including TNF-α) play a key role in the development of OM. Genetic alterations, i.e. single nucleotide polymorphisms (SNPs) within genes encoding for receptors for TNF (ie. TNFRSF1A) may change their function. The aim of this study was to investigate relationship between a polymorphism of TNFRSF1A and occurrence and severity of acute reaction after RTH for HNC patients. Data from 58 HNC patients (stages I-IV) were analyzed. All of them were irradiated using IMRT technique with doses 50-70Gy. Oral mucositis (OM) was evaluated according to RTOG/EORTC guidelines. DNA from HNC patients were isolated from whole blood and genotypes were determined by sequencing method. Patients with TT or GT genotype demonstrated higher risk of manifestation of grade 3 OM in 5th week of RTH (p=0.041; OR=9.240; 95% CI: 1.101–77.581) compared to GG carriers. Similarly, high risk of grade 3 OM in patients with T allele presence was noted in 6th week (p=0.030; OR=10.50; 95%CI:1.257–87.690) and in 7th week (p=0.008; OR=5.625; 95% CI: 1.584–19.975) of treatment compared to patients with GG homozygote. Our results indicate an association between SNP of TNFRSF1A (rs4149570) gene and risk of more severe OM related to radiation therapy for HNC patients. Springer Netherlands 2017-04-11 2018 /pmc/articles/PMC5736772/ /pubmed/28401452 http://dx.doi.org/10.1007/s12253-017-0227-1 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Brzozowska, Anna Powrózek, Tomasz Homa-Mlak, Iwona Mlak, Radosław Ciesielka, Marzanna Gołębiowski, Paweł Małecka-Massalska, Teresa Polymorphism of Promoter Region of TNFRSF1A Gene (−610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients |
title | Polymorphism of Promoter Region of TNFRSF1A Gene (−610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients |
title_full | Polymorphism of Promoter Region of TNFRSF1A Gene (−610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients |
title_fullStr | Polymorphism of Promoter Region of TNFRSF1A Gene (−610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients |
title_full_unstemmed | Polymorphism of Promoter Region of TNFRSF1A Gene (−610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients |
title_short | Polymorphism of Promoter Region of TNFRSF1A Gene (−610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients |
title_sort | polymorphism of promoter region of tnfrsf1a gene (−610 t > g) as a novel predictive factor for radiotherapy induced oral mucositis in hnc patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736772/ https://www.ncbi.nlm.nih.gov/pubmed/28401452 http://dx.doi.org/10.1007/s12253-017-0227-1 |
work_keys_str_mv | AT brzozowskaanna polymorphismofpromoterregionoftnfrsf1agene610tgasanovelpredictivefactorforradiotherapyinducedoralmucositisinhncpatients AT powrozektomasz polymorphismofpromoterregionoftnfrsf1agene610tgasanovelpredictivefactorforradiotherapyinducedoralmucositisinhncpatients AT homamlakiwona polymorphismofpromoterregionoftnfrsf1agene610tgasanovelpredictivefactorforradiotherapyinducedoralmucositisinhncpatients AT mlakradosław polymorphismofpromoterregionoftnfrsf1agene610tgasanovelpredictivefactorforradiotherapyinducedoralmucositisinhncpatients AT ciesielkamarzanna polymorphismofpromoterregionoftnfrsf1agene610tgasanovelpredictivefactorforradiotherapyinducedoralmucositisinhncpatients AT gołebiowskipaweł polymorphismofpromoterregionoftnfrsf1agene610tgasanovelpredictivefactorforradiotherapyinducedoralmucositisinhncpatients AT małeckamassalskateresa polymorphismofpromoterregionoftnfrsf1agene610tgasanovelpredictivefactorforradiotherapyinducedoralmucositisinhncpatients |